Hepatitis A and B vaccines added to the list of medicines that cannot be parallel exported from the UK

Hepatitis A and B vaccines added to the list of medicines that cannot be parallel exported from the UK

November 13, 2019

Further to our news story Temporary parallel export ban issued to ensure continued supply of medicines the Department of Health and Social Care (DHSC) and the Medicines and Healthcare products Regulatory Agency (MHRA) has announced that Hepatitis A and B vaccine are to be added to the list of medicines which must not be parallel exported from the UK. The restriction on the following lines came into effect from 00:00am 14 November 2019:

  • Hepatitis A and B vaccine

Read the DHSC/MHRA letter to holders of a wholesale dealer licence

View the latest list of medicines that cannot be parallel exported from the UK (updated 13/11/19)

The list, will continue to be reviewed on an ongoing basis, to include any product that meets the following criteria:

  1. the medicine is required to meet the needs of UK patients;
  2. the medicine is either being parallel exported or is at threat of being parallel exported; and
  3. the export of that medicine is either contributing to, or may contribute to, a shortage of that medicine in the UK.

The list currently includes products such as Adrenaline auto-injectors, Estradiol, Hepatitis B (rDNA) suspension for injection, Levonorgestrel and Progesterone.

See our page here for the full list of medicines that cannot be parallel exported from the UK.

 



Posted in: ,


More Latest News >

Metformin Safety Update

The Medicines and Healthcare products Regulatory Agency (MHRA) has been made aware that outside of the UK very low amounts...

PQS: NSAID quality criterion

This news story highlights several points on the non-steroidal anti-inflammatory drug (NSAID) quality criterion of the Pharmacy Quality Scheme (PQS)...